triazoles has been researched along with fluoxetine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (48.65) | 18.2507 |
2000's | 15 (40.54) | 29.6817 |
2010's | 4 (10.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ieni, JR; Knight, DL; Nemeroff, CB; Owens, MJ; Winders, K | 1 |
Anton, SF; Revicki, DA | 1 |
Preskorn, SH | 1 |
Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC | 1 |
Castañeda, R; Levy, R; Sussman, N; Westreich, LM | 1 |
Brown, RE; Culpepper, L; Gonzales, J; Hales, RE; Keller, MB; Revicki, DA | 1 |
Möller, HJ; Volz, HP | 1 |
Armitage, R; Cole, D; Rush, AJ; Yonkers, K | 1 |
Albala, BJ; Erman, MK; Gillin, JC; Rapaport, M; Winokur, A | 1 |
Benazzi, F | 1 |
Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA | 1 |
Richelson, E | 1 |
Anton, SF; Bakish, D; Brown, RE; Feeny, D; Palmer, W; Revicki, DA; Rosser, WW | 1 |
Benfield, P; Wilde, MI | 1 |
Thase, ME | 1 |
Churchill, E; Davidson, JR; Meltzer-Brody, S | 1 |
Smith, DL; Wenegrat, BG | 1 |
Davidson, JR | 1 |
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
Jurima-Romet, M; Neigh, S; Wright, M | 1 |
Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
Ferguson, JM | 1 |
Baruch, Y; Chelben, J; Lustig, M; Strous, RD | 1 |
Keller, MB | 1 |
Alfaro, CL; Ereshefsky, L; Lam, YW; Miller, M | 1 |
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
Boot, JR; Broadmore, RJ; Cooper, J; Eyre, TA; Mitchell, SN; Pullar, IA; Sanger, GJ; Wedley, S | 1 |
Albert, PR; Bakish, D; Du, L; Hrdina, P; Lemonde, S | 1 |
Martényi, F | 1 |
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
Papakostas, GI; Shelton, RC | 1 |
Kelly, BD | 1 |
Contento Salcedo, AM; Muñoz Fernández, L; Rodríguez-Flores, J | 1 |
Dalla, C; Kafetzopoulos, V; Kokras, N; Mavridis, T; Pastromas, N; Porto, TH | 1 |
Fernández-Guasti, A; García-Cárdenas, N; Gómez-Quintanar, BN; Olvera-Hernández, S | 1 |
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
Chai, HH; Chen, GZ; Chen, WX; Chen, YS; Fu, XC; Guo, YW; Li, SP; Ma, L; Song, MY; Sun, HT; Tan, MX | 1 |
11 review(s) available for triazoles and fluoxetine
Article | Year |
---|---|
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
The safety profile of nefazodone.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain | 1996 |
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Pharmacokinetic interactions of antidepressants.
Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Fluoxetine. A pharmacoeconomic review of its use in depression.
Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Health Care Costs; Humans; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Triazoles | 1998 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Fluoxetine; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles | 2000 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
[Three paradigms in the treatment of posttraumatic stress disorder].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Combat Disorders; Controlled Clinical Trials as Topic; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Triazoles | 2005 |
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
6 trial(s) available for triazoles and fluoxetine
Article | Year |
---|---|
A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Triazoles | 1997 |
A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Topics: Adult; Affect; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Treatment Outcome; Triazoles | 1997 |
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Circadian Rhythm; Comorbidity; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles; Wakefulness | 1998 |
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
Topics: Adult; Antidepressive Agents; Cohort Studies; Combat Disorders; Disasters; Female; Fluoxetine; Fluvoxamine; Humans; Lamotrigine; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Rape; Reproducibility of Results; Stress Disorders, Post-Traumatic; Triazines; Triazoles | 1999 |
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Ketoconazole; Male; Midazolam; Piperazines; Triazoles | 2003 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
20 other study(ies) available for triazoles and fluoxetine
Article | Year |
---|---|
The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
Topics: Animals; Antidepressive Agents; Carrier Proteins; Cerebral Cortex; Dose-Response Relationship, Drug; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Triazoles | 1995 |
The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
Topics: Antidepressive Agents; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Models, Economic; Piperazines; Treatment Outcome; Triazoles | 1995 |
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride | 1996 |
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Drug Costs; Fluoxetine; Health Care Costs; Health Policy; Health Services; Humans; Imipramine; Managed Care Programs; Patient Compliance; Piperazines; Probability; Quality-Adjusted Life Years; Treatment Failure; Treatment Outcome; Triazoles | 1997 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Modelling the cost effectiveness of antidepressant treatment in primary care.
Topics: Antidepressive Agents; Decision Support Techniques; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Markov Chains; Models, Economic; Piperazines; Primary Health Care; Quality-Adjusted Life Years; Sensitivity and Specificity; Triazoles | 1995 |
A case report of serotonin syndrome associated with combined nefazodone and fluoxetine.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Triazoles | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
Topics: Alkylation; Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Histamine H1 Antagonists; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Sertraline; Terfenadine; Triazoles | 1998 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles | 2000 |
Remission of SSRI-induced akathisia after switch to nefazodone.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles | 2001 |
Long-term treatment of recurrent and chronic depression.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles | 2001 |
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Topics: Animals; Autoreceptors; Cerebral Cortex; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Guinea Pigs; Hypothalamus; Indoles; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Piperidines; Piperidones; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Presynaptic; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Spiro Compounds; Subcellular Fractions; Triazoles; Tritium; United Kingdom | 2004 |
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzimidazoles; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Piperazines; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Triazoles | 2004 |
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles | 2008 |
Do new-generation antidepressants work?
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2008 |
Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC.
Topics: Chromatography, Micellar Electrokinetic Capillary; Female; Fluoxetine; Humans; Hydrogen-Ion Concentration; Letrozole; Methanol; Nitriles; Reproducibility of Results; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Temperature; Triazoles; Water Pollutants, Chemical; Water Supply | 2009 |
Acute but not sustained aromatase inhibition displays antidepressant properties.
Topics: Animals; Antidepressive Agents; Aromatase Inhibitors; Drug Administration Schedule; Estradiol; Female; Fluoxetine; Immobility Response, Tonic; Letrozole; Nitriles; Progesterone; Rats; Testosterone; Triazoles | 2014 |
Male rats with same sex preference show high experimental anxiety and lack of anxiogenic-like effect of fluoxetine in the plus maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Enzyme Inhibitors; Exploratory Behavior; Female; Fluoxetine; Homosexuality, Male; Letrozole; Male; Motor Activity; Nitriles; Rats; Rats, Wistar; Sex Characteristics; Triazoles | 2015 |
The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Brain-Derived Neurotrophic Factor; Chemokine CXCL1; Depression; Fluoxetine; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Phenylurea Compounds; Receptors, Interleukin-8B; Stress, Psychological; Thiazoles; Triazoles; Urea | 2019 |